Dr Brian Hargreaves, Global Sector Head – Healthcare, 3i plc
Dr. Arnoud Dijkstra, Director Business Development, Actelion Pharmaceuticals
Joel Besse, Senior Partner, Atlas Venture
Dr. Jesper Zeuthen, Managing Director, BankInvest Biomedical Venture
Dr. Carles Domenech, Director, Biotech Investments, Barcelona Empren
Stephan Meier, Partner, BB Medtech
Michael Levy, Vice President, Alliance Management, Bristol Myers Squibb
Dr Hervé de Kergrohen, Vantage Partner, CDC IXIS Innovation
Stephanie Leouzon, Managing Director, European Healthcare, Credit Suisse First Boston
Dimitri Dimitriou, Chief Executive Officer, DyoDelta
Dr. Giancarlo Mennella, Managing Director, Egamid Ltd
Heinrich Christen, Partner, Ernst & Young
Dr. Frank Grams, Global Alliance Director, F. Hoffman-La Roche Ltd
Dr Peter Reinisch, Partner, Global Life Science Ventures
Andreas Wicki, CEO, HBM Partners
Tom Geimer, Partner, Heidelberg Innovation
Stan Yakatan, Chairman, Katan Associates
Sandrine Cailleteau, Head, Business Development & Licensing, Laboratoires Fournier
Dr Elmar Ledergerber, Mayor of Zurich
Christopher Meyer, Head of Business Development and Strategic Planning, Medtronic Europe SàRL
Guy Eiferman, Vice President Alliance Management, Merck & Co
Dr Denise Pollard-Knight, Head of Nomura Phase4 Ventures, Nomura Phase4 Ventures
Dr Rudolf Gygax, Managing Director, Novartis Venture Fund, Novartis International
Anthony Rosenberg, Global Head Business Development & Licensing, Novartis Pharma
Dennis Purcell, Managing Director, Perseus-Soros BioPharmaceutical Fund
Christof Lenz, Siemens Medical Solutions
Antoine Papiernik, Managing Partner, Sofinnova
Domenico Alexakis, executive Director, Swiss Biotech Association
Yvonne Wegmann, Vice President, Head of Issuers & Investor Relations, SWX Swiss Exchange
Dr Alexandra Goll, General Partner, Techno Venture Management (TVM)
Nick Lowcock, Managing Director, Warburg Pincus